Bristol Myers Squibb (BMYMP) Minority Interest (2016 - 2025)
Historic Minority Interest for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $33.0 million.
- Bristol Myers Squibb's Minority Interest fell 3773.58% to $33.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $33.0 million, marking a year-over-year decrease of 3773.58%. This contributed to the annual value of $33.0 million for FY2025, which is 3773.58% down from last year.
- Per Bristol Myers Squibb's latest filing, its Minority Interest stood at $33.0 million for Q4 2025, which was down 3773.58% from $48.0 million recorded in Q3 2025.
- Bristol Myers Squibb's Minority Interest's 5-year high stood at $71.0 million during Q3 2021, with a 5-year trough of $33.0 million in Q4 2025.
- Its 5-year average for Minority Interest is $58.3 million, with a median of $58.5 million in 2024.
- Its Minority Interest has fluctuated over the past 5 years, first surged by 303.03% in 2021, then tumbled by 3773.58% in 2025.
- Bristol Myers Squibb's Minority Interest (Quarter) stood at $60.0 million in 2021, then fell by 5.0% to $57.0 million in 2022, then fell by 3.51% to $55.0 million in 2023, then fell by 3.64% to $53.0 million in 2024, then tumbled by 37.74% to $33.0 million in 2025.
- Its Minority Interest stands at $33.0 million for Q4 2025, versus $48.0 million for Q3 2025 and $54.0 million for Q2 2025.